{"id":47221,"date":"2017-03-03T03:29:27","date_gmt":"2017-03-02T21:59:27","guid":{"rendered":"https:\/\/www.legalindia.com\/news\/?p=47221"},"modified":"2017-03-03T03:29:27","modified_gmt":"2017-03-02T21:59:27","slug":"biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told","status":"publish","type":"post","link":"https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told","title":{"rendered":"Biocon, Mylan breast cancer drugs approved by DCGI: HC told"},"content":{"rendered":"<figure id=\"attachment_46468\" aria-describedby=\"caption-attachment-46468\" style=\"width: 300px\" class=\"wp-caption alignright\"><a href=\"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg?ssl=1\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" data-attachment-id=\"46468\" data-permalink=\"https:\/\/www.legalindia.com\/news\/dishonest-recording-proceedings-injustice-hc\/delhi-hc-2\" data-orig-file=\"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg?fit=759%2C422&amp;ssl=1\" data-orig-size=\"759,422\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"delhi-hc\" data-image-description=\"\" data-image-caption=\"\" data-large-file=\"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg?fit=640%2C356&amp;ssl=1\" class=\"wp-image-46468 size-medium\" src=\"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg?resize=300%2C167&#038;ssl=1\" alt=\"Biocon, Mylan breast cancer drugs approved by DCGI: HC told\" width=\"300\" height=\"167\" srcset=\"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg?resize=300%2C167&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg?resize=150%2C83&amp;ssl=1 150w, https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg?w=759&amp;ssl=1 759w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><figcaption id=\"caption-attachment-46468\" class=\"wp-caption-text\">Biocon, Mylan breast cancer drugs approved by DCGI: HC told<\/figcaption><\/figure>\n<p>Swiss pharma major Roche cannot prima facie have a say against the sale and marketing of breast cancer medicines of drug firms Biocon and Mylan once the Drugs Controller General of India (DCGI) has approved it, Delhi High Court said today.<\/p>\n<p>&#8220;Once the designated authority has given approval, you cannot say prima facie you have case over that. Till that (approval) is disturbed by an order of the court, it will remain,&#8221; a bench of justices Badar Durrez Ahmed and Sanjeev Sachdeva said.<\/p>\n<p>The observation of the court came after the DCGI, represented by Additional Solicitor General Sanjay Jain, confirmed that the medicines and the package inserts of the two companies were granted approval for marketing and sale.<\/p>\n<p>The confirmation came in response to the court&#8217;s query of February 22 to DCGI on whether the package inserts of Biocon and Mylan have been approved by the authority.<\/p>\n<p>The court was hearing the pleas of Roche and other pharma firms like Biocon, Mylan and Reliance Life Sciences, on the issue of marketing and sale of generic drugs biosimilar to the Swiss company&#8217;s Trastuzumab.<\/p>\n<p>It is Roche&#8217;s contention that Biocon, Mylan and Reliance cannot term their medicine as merely Trastuzumab and ought to call it Biocon&#8217;s Trastuzumab or Mylan&#8217;s Trastuzumab as these companies have not followed the entire protocol of tests and studies, as was done by it.<\/p>\n<p>During the arguments today, Roche contended that the approvals were not granted properly and Mylan has not even carried out clinical trials.<\/p>\n<p>In response, Biocon said it manufactures the medicine for both the companies, but they sell it under different names.<\/p>\n<p>While Biocon sells it as Canmab, Mylan sells it under the name of Hertraz, the court was told.<\/p>\n<p>Both companies said the DCGI had asked them to quote the clinical data of Roche&#8217;s cancer medication, Trastuzumab, in their respective package inserts, which are the slips of paper inside each medicine box containing details of the drug.<\/p>\n<p>( Source &#8211; PTI )<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Swiss pharma major Roche cannot prima facie have a say against the sale and marketing of breast cancer medicines of drug firms Biocon and Mylan once the Drugs Controller General of India (DCGI) has approved it, Delhi High Court said today. &#8220;Once the designated authority has given approval, you cannot say prima facie you have [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":46468,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[38833,38831,146,38836,255,38832,38835,31987,117,80,38834],"class_list":["post-47221","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-top-law-news","tag-biocon","tag-breast-cancer-medicines","tag-court","tag-dcgi","tag-delhi-high-court","tag-drug-firms","tag-drugs-controller-general-of-india","tag-featured","tag-law","tag-legal-news","tag-mylan"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biocon, Mylan breast cancer drugs approved by DCGI: HC told - Legal News India - Supreme Court &amp; High Court Updates<\/title>\n<meta name=\"description\" content=\"Swiss pharma major Roche cannot prima facie have a say against the sale and marketing of breast cancer medicines of drug firms Biocon and Mylan once the - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biocon, Mylan breast cancer drugs approved by DCGI: HC told - Legal News India - Supreme Court &amp; High Court Updates\" \/>\n<meta property=\"og:description\" content=\"Swiss pharma major Roche cannot prima facie have a say against the sale and marketing of breast cancer medicines of drug firms Biocon and Mylan once the - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told\" \/>\n<meta property=\"og:site_name\" content=\"Legal News India - Supreme Court &amp; High Court Updates\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LegalindiaCom\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-03-02T21:59:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"759\" \/>\n\t<meta property=\"og:image:height\" content=\"422\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Legal India Admin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Legal India Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told\"},\"author\":{\"name\":\"Legal India Admin\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#\\\/schema\\\/person\\\/0bfdffe9059fb8bb24a86d094609c5ea\"},\"headline\":\"Biocon, Mylan breast cancer drugs approved by DCGI: HC told\",\"datePublished\":\"2017-03-02T21:59:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told\"},\"wordCount\":358,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/01\\\/delhi-hc.jpg?fit=759%2C422&ssl=1\",\"keywords\":[\"Biocon\",\"breast cancer medicines\",\"Court\",\"DCGI\",\"Delhi High Court\",\"drug firms\",\"Drugs Controller General of India\",\"featured\",\"Law\",\"Legal News\",\"Mylan\"],\"articleSection\":[\"Top Law News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.legalindia.com\\\/news\\\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told\",\"url\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told\",\"name\":\"Biocon, Mylan breast cancer drugs approved by DCGI: HC told - Legal News India - Supreme Court &amp; High Court Updates\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/01\\\/delhi-hc.jpg?fit=759%2C422&ssl=1\",\"datePublished\":\"2017-03-02T21:59:27+00:00\",\"description\":\"Swiss pharma major Roche cannot prima facie have a say against the sale and marketing of breast cancer medicines of drug firms Biocon and Mylan once the - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.legalindia.com\\\/news\\\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/01\\\/delhi-hc.jpg?fit=759%2C422&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/01\\\/delhi-hc.jpg?fit=759%2C422&ssl=1\",\"width\":759,\"height\":422},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Top Law News\",\"item\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/category\\\/top-law-news\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Biocon, Mylan breast cancer drugs approved by DCGI: HC told\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#website\",\"url\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/\",\"name\":\"Legal News India - Supreme Court & High Court Updates\",\"description\":\"Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#organization\"},\"alternateName\":\"Legal News India for Advocates, Lawyers & Law Students\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#organization\",\"name\":\"Legal News India: Supreme Court, High Courts & Govt Updates\",\"alternateName\":\"Legal News India for Advocates, Lawyers & Law Students\",\"url\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2018\\\/05\\\/538552_367793346590451_81997783_n.jpg?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.legalindia.com\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2018\\\/05\\\/538552_367793346590451_81997783_n.jpg?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"Legal News India: Supreme Court, High Courts & Govt Updates\"},\"image\":{\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/LegalindiaCom\\\/\",\"https:\\\/\\\/x.com\\\/Legal_india\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/#\\\/schema\\\/person\\\/0bfdffe9059fb8bb24a86d094609c5ea\",\"name\":\"Legal India Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g\",\"caption\":\"Legal India Admin\"},\"sameAs\":[\"https:\\\/\\\/www.legalindia.com\",\"https:\\\/\\\/x.com\\\/legaliadmin\"],\"url\":\"https:\\\/\\\/www.legalindia.com\\\/news\\\/author\\\/legal-india-admin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biocon, Mylan breast cancer drugs approved by DCGI: HC told - Legal News India - Supreme Court &amp; High Court Updates","description":"Swiss pharma major Roche cannot prima facie have a say against the sale and marketing of breast cancer medicines of drug firms Biocon and Mylan once the - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told","og_locale":"en_US","og_type":"article","og_title":"Biocon, Mylan breast cancer drugs approved by DCGI: HC told - Legal News India - Supreme Court &amp; High Court Updates","og_description":"Swiss pharma major Roche cannot prima facie have a say against the sale and marketing of breast cancer medicines of drug firms Biocon and Mylan once the - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.","og_url":"https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told","og_site_name":"Legal News India - Supreme Court &amp; High Court Updates","article_publisher":"https:\/\/www.facebook.com\/LegalindiaCom\/","article_published_time":"2017-03-02T21:59:27+00:00","og_image":[{"width":759,"height":422,"url":"https:\/\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg","type":"image\/jpeg"}],"author":"Legal India Admin","twitter_misc":{"Written by":"Legal India Admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told#article","isPartOf":{"@id":"https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told"},"author":{"name":"Legal India Admin","@id":"https:\/\/www.legalindia.com\/news\/#\/schema\/person\/0bfdffe9059fb8bb24a86d094609c5ea"},"headline":"Biocon, Mylan breast cancer drugs approved by DCGI: HC told","datePublished":"2017-03-02T21:59:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told"},"wordCount":358,"commentCount":0,"publisher":{"@id":"https:\/\/www.legalindia.com\/news\/#organization"},"image":{"@id":"https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg?fit=759%2C422&ssl=1","keywords":["Biocon","breast cancer medicines","Court","DCGI","Delhi High Court","drug firms","Drugs Controller General of India","featured","Law","Legal News","Mylan"],"articleSection":["Top Law News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told","url":"https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told","name":"Biocon, Mylan breast cancer drugs approved by DCGI: HC told - Legal News India - Supreme Court &amp; High Court Updates","isPartOf":{"@id":"https:\/\/www.legalindia.com\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told#primaryimage"},"image":{"@id":"https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg?fit=759%2C422&ssl=1","datePublished":"2017-03-02T21:59:27+00:00","description":"Swiss pharma major Roche cannot prima facie have a say against the sale and marketing of breast cancer medicines of drug firms Biocon and Mylan once the - Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.","breadcrumb":{"@id":"https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told#primaryimage","url":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg?fit=759%2C422&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg?fit=759%2C422&ssl=1","width":759,"height":422},{"@type":"BreadcrumbList","@id":"https:\/\/www.legalindia.com\/news\/biocon-mylan-breast-cancer-drugs-approved-dcgi-hc-told#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.legalindia.com\/news\/"},{"@type":"ListItem","position":2,"name":"Top Law News","item":"https:\/\/www.legalindia.com\/news\/category\/top-law-news"},{"@type":"ListItem","position":3,"name":"Biocon, Mylan breast cancer drugs approved by DCGI: HC told"}]},{"@type":"WebSite","@id":"https:\/\/www.legalindia.com\/news\/#website","url":"https:\/\/www.legalindia.com\/news\/","name":"Legal News India - Supreme Court & High Court Updates","description":"Get the latest legal news from the Supreme Court, High Courts, and government. Essential updates on judgements, acts, and in-depth analysis for lawyers, advocates, and law students in India.","publisher":{"@id":"https:\/\/www.legalindia.com\/news\/#organization"},"alternateName":"Legal News India for Advocates, Lawyers & Law Students","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.legalindia.com\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.legalindia.com\/news\/#organization","name":"Legal News India: Supreme Court, High Courts & Govt Updates","alternateName":"Legal News India for Advocates, Lawyers & Law Students","url":"https:\/\/www.legalindia.com\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.legalindia.com\/news\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2018\/05\/538552_367793346590451_81997783_n.jpg?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2018\/05\/538552_367793346590451_81997783_n.jpg?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"Legal News India: Supreme Court, High Courts & Govt Updates"},"image":{"@id":"https:\/\/www.legalindia.com\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LegalindiaCom\/","https:\/\/x.com\/Legal_india"]},{"@type":"Person","@id":"https:\/\/www.legalindia.com\/news\/#\/schema\/person\/0bfdffe9059fb8bb24a86d094609c5ea","name":"Legal India Admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4faa9d728ed1af3b73d52225c7f12901ac726fe6f7ea0a3348a1d51f3a930987?s=96&d=mm&r=g","caption":"Legal India Admin"},"sameAs":["https:\/\/www.legalindia.com","https:\/\/x.com\/legaliadmin"],"url":"https:\/\/www.legalindia.com\/news\/author\/legal-india-admin"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/01\/delhi-hc.jpg?fit=759%2C422&ssl=1","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":53774,"url":"https:\/\/www.legalindia.com\/news\/delhi-high-court-suspends-centres-ban-on-oxytocin-drug","url_meta":{"origin":47221,"position":0},"title":"Delhi High Court suspends, Centre&#8217;s ban on Oxytocin drug","author":"Legal India Admin","date":"September 1, 2018","format":false,"excerpt":"NEW DELHI:\u00a0The Delhi High Court Friday passed an interim order to\u00a0\u00a0suspended for a month the Centre's ban on private companies producing and distributing oxytocin.\u00a0The Centre had issued a notification to implement this ban from September 1. The court was hearing pleas of Mylan Laboratories\u2019 subsidiary BGP Products Operations GmbH, Neon\u2026","rel":"","context":"In &quot;Top Law News&quot;","block_context":{"text":"Top Law News","link":"https:\/\/www.legalindia.com\/news\/category\/top-law-news"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2018\/09\/hammer1.jpg?fit=759%2C422&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2018\/09\/hammer1.jpg?fit=759%2C422&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2018\/09\/hammer1.jpg?fit=759%2C422&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2018\/09\/hammer1.jpg?fit=759%2C422&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":45988,"url":"https:\/\/www.legalindia.com\/news\/delhi-hc-quashes-ban-344-fixed-dose-combo-medicines","url_meta":{"origin":47221,"position":1},"title":"Delhi HC quashes ban on 344 fixed dose combo medicines","author":"Legal India News","date":"December 1, 2016","format":false,"excerpt":"In a blow to the Centre, its decision to ban 344 fixed dose combination (FDC) medicines, including well known brands like Corex cough syrup, Vicks Action 500 extra and several anti-diabetes medication, was today set aside by the Delhi High Court which said the step was taken in a \"haphazard\u2026","rel":"","context":"In &quot;Top Law News&quot;","block_context":{"text":"Top Law News","link":"https:\/\/www.legalindia.com\/news\/category\/top-law-news"},"img":{"alt_text":"Delhi HC quashes ban on 344 fixed dose combo medicines","src":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2016\/08\/Law-300x200.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":27517,"url":"https:\/\/www.legalindia.com\/news\/sc-rejects-plea-of-novartis-for-patent-of-glivec-drug","url_meta":{"origin":47221,"position":2},"title":"SC rejects plea of Novartis for patent of Glivec drug","author":"Legal India Admin","date":"April 2, 2013","format":false,"excerpt":"The\u00a0Supreme Court cleared the decks for Indian drug manufacturing companies to make available life saving medicines to patients in India at a cheaper rate, by coming to the rescue of cancer patients. A bench comprising Justices Aftab Alam and Ranjana Prakash Desai dismissed a petition of Swiss pharma giant Novartis\u2026","rel":"","context":"In &quot;Top Law News&quot;","block_context":{"text":"Top Law News","link":"https:\/\/www.legalindia.com\/news\/category\/top-law-news"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":40702,"url":"https:\/\/www.legalindia.com\/news\/drug-patent-war-fm-auction-coal-ordinance-kept-delhi-hc-busy","url_meta":{"origin":47221,"position":3},"title":"Drug patent war, FM auction, coal ordinance kept Delhi HC busy","author":"Legal India News","date":"January 2, 2016","format":false,"excerpt":"The patent war involving domestic and multi-national pharma majors, tussle between the Centre and a private radio channel over FM auctions kept the Delhi High Court\u00a0busy in 2015 during which it also rapped the Centre for its coal auction ordinance by saying that the legislation \"lacked clarity\". The hastily-formulated coal\u2026","rel":"","context":"In &quot;Top Law News&quot;","block_context":{"text":"Top Law News","link":"https:\/\/www.legalindia.com\/news\/category\/top-law-news"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2015\/08\/NCDRC.jpg?fit=420%2C239&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":57658,"url":"https:\/\/www.legalindia.com\/news\/circulated-order-staying-online-sale-of-medicines-to-states-centre","url_meta":{"origin":47221,"position":4},"title":"Circulated order staying online sale of medicines to states: Centre","author":"Legal India Admin","date":"September 26, 2019","format":false,"excerpt":"The Centre told the Delhi High Court Tuesday that it has informed all state drug controlling authorities about the interim order barring online sale of medicines and has directed them to take requisite action under the Drugs and Cosmetics (D&C) Act and Rules. The submission was made before a bench\u2026","rel":"","context":"In &quot;Top Law News&quot;","block_context":{"text":"Top Law News","link":"https:\/\/www.legalindia.com\/news\/category\/top-law-news"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2019\/09\/medicines.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":50931,"url":"https:\/\/www.legalindia.com\/news\/sc-relook-349-fdc-medicines-drug-advisory-board","url_meta":{"origin":47221,"position":5},"title":"SC for relook into 349 FDC medicines by drug advisory board","author":"Legal India Admin","date":"December 18, 2017","format":false,"excerpt":"Pharmaceutical firms have suffered a setback as the Supreme Court has favoured re- examination of 349 fixed dose combination (FDC) medicines, a ban on which was set aside by the Delhi High Court. The FDC medicines, including well-known brands such as Corex cough syrup and Vicks Action 500 Extra and\u2026","rel":"","context":"In &quot;High Profile Cases&quot;","block_context":{"text":"High Profile Cases","link":"https:\/\/www.legalindia.com\/news\/category\/high-profile-cases"},"img":{"alt_text":"SC for relook into 349 FDC medicines by drug advisory board","src":"https:\/\/i0.wp.com\/www.legalindia.com\/news\/wp-content\/uploads\/sites\/2\/2017\/08\/judiciary.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"jetpack_shortlink":"https:\/\/wp.me\/p6H5Bf-chD","jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/posts\/47221","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/comments?post=47221"}],"version-history":[{"count":0,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/posts\/47221\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/media\/46468"}],"wp:attachment":[{"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/media?parent=47221"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/categories?post=47221"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.legalindia.com\/news\/wp-json\/wp\/v2\/tags?post=47221"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}